ALLR Allarity Therapeutics, Inc.

NASDAQ
$0.87

Allarity Therapeutics, Inc. (ALLR) is expected to report earnings on February 12, 2027, before the market open. The consensus earnings estimate is $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.0% since its last earnings release on November 13, 2026.

Allarity Therapeutics Missed Consensus Estimates, Guides Above Estimates
Friday, November 13, 2026 · 8:05 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 12
Friday · 8:00 AM ET
Earnings Whisper
-
vs $0.03
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.89

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Allarity Therapeutics, Inc.

Allarity Therapeutics Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel oncology therapeutics together with drug-specific DRP(R) companion diagnostics for personalized cancer care. Allarity Therapeutics Inc. is based in Cambridge, MA U.S.A.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.